The Latest Analyst Ratings for IDEAYA Biosciences
Portfolio Pulse from Benzinga Insights
IDEAYA Biosciences (NASDAQ:IDYA) has received positive analyst ratings in the last quarter, with 2 bullish and 6 somewhat bullish ratings, and no indifferent, somewhat bearish, or bearish ratings. The average 12-month price target for IDYA is $38.75, with a high of $44.00 and a low of $32.00. This target has increased by 8.24% over the past month. Analysts rate stocks based on future earnings potential and company risk profile, typically updating their ratings quarterly or after significant company events.
November 13, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
IDEAYA Biosciences has received predominantly positive ratings from analysts, with an average price target that has recently increased, suggesting a favorable outlook for the stock.
The positive analyst ratings and the increase in the average price target over the past month indicate a strong bullish sentiment towards IDYA. This could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100